Truxima®
Non-Hodgkin's Lymphoma
CommercialApproved/Marketing
Key Facts
About Celltrion
Celltrion is a global biopharmaceutical company headquartered in South Korea that specializes in the development, manufacturing, and commercialization of biosimilar and innovative biologics. The company operates Korea's largest global R&D center and was the first in Asia to operate US FDA cGMP certified animal cell culture facilities. With direct sales networks across major global markets including the US and Europe, Celltrion has established itself as the No. 1 manufacturer and exporter of biosimilars in Korea. The company recently acquired a former Eli Lilly facility in Branchburg, New Jersey to establish local US manufacturing capabilities.
View full company profileTherapeutic Areas
Other Non-Hodgkin's Lymphoma Drugs
| Drug | Company | Phase |
|---|---|---|
| Rituximab Biosimilar | Changchun High-Tech Industry | Phase 3 |